Literature DB >> 35415299

Flexible polymeric patch based nanotherapeutics against non-cancer therapy.

Houjuan Zhu1, Justin Mah Jian Qiang1,2, Chen Gang Wang1, Chui Yu Chan1, Qiang Zhu1, Enyi Ye1,3, Zibiao Li1,3, Xian Jun Loh1.   

Abstract

Flexible polymeric patches find widespread applications in biomedicine because of their biological and tunable features including excellent patient compliance, superior biocompatibility and biodegradation, as well as high loading capability and permeability of drug. Such polymeric patches are classified into microneedles (MNs), hydrogel, microcapsule, microsphere and fiber depending on the formed morphology. The combination of nanomaterials with polymeric patches allows for improved advantages of increased curative efficacy and lowered systemic toxicity, promoting on-demand and regulated drug administration, thus providing the great potential to their clinic translation. In this review, the category of flexible polymeric patches that are utilized to integrate with nanomaterials is briefly presented and their advantages in bioapplications are further discussed. The applications of nanomaterials embedded polymeric patches in non-cancerous diseases were also systematically reviewed, including diabetes therapy, wound healing, dermatological disease therapy, bone regeneration, cardiac repair, hair repair, obesity therapy and some immune disease therapy. Alternatively, the limitations, latest challenges and future perspectives of such biomedical therapeutic devices are addressed.
© 2022 The Authors.

Entities:  

Keywords:  Biomedical scaffolds; Flexible polymeric patches; Hydrogel; Microneedle; Nanomaterials; Non-cancer therapy

Year:  2022        PMID: 35415299      PMCID: PMC8971585          DOI: 10.1016/j.bioactmat.2022.03.034

Source DB:  PubMed          Journal:  Bioact Mater        ISSN: 2452-199X


Introduction

Nowadays, polymeric materials have been widely applied in biomedical fields and are favored in the development of tailor-made therapeutic devices owing to their biocompatibility, processability, and low cost [[1], [2], [3]]. Currently, soft materials based polymeric patches are extensively used as biomedical scaffolds for drug encapsulation or implantation due to their design flexibility and their ease to be endowed with stimuli-responsive features. In recent years, such polymers could be applied as several types of polymeric patches depended on the forming structure, such as microneedles (MNs), hydrogels, microcapsules, microspheres, and fibers. Such polymeric flexible matrixes are endowed with superior biocompatibility and biodegradability, avoiding an immunological response to a foreign substance and the easy patch removal after surgery [4]. Besides for this, their hydrophilicity also could endow the hydrophobic therapeutic agents with long-term and internal stability during delivery process [4]. However, polymeric matrixes are most fabricated as the reservoir of nanoagents in diseases treatments. Up to now, nanomaterials have been greatly employed as nanoagents for versatile nanomedical theranostics in light of inherent performances of different therapy modals [5,6]. Taking advantages of superior photothermal, electronic, optical, catalytic, magnetic, physical, and chemical features, these nanomaterials have been widely explored in various therapeutic modals, such as chemotherapy (CHT) [7,8], photothermal therapy (PTT) [[9], [10], [11]], photodynamic therapy (PDT) [[12], [13], [14], [15]], chemodynamic therapy (CDT) [[16], [17], [18]], magnetothermal therapy [19,20], immunotherapy [[21], [22], [23]], radiotherapy (RT) [24,25], gene therapy [26,27] and starvation therapy (ST) [28]. However, non-cancer treatment has a number of disadvantages when used alone, including long-term accumulation, high toxicity, instability and low bioavailability, limiting their future clinic application. Through combining separate advantages of flexible polymeric patches and nanomaterials, nanomaterials embedded polymeric patches have received much attention of various therapeutic in bioapplication [26,[29], [30], [31], [32]]. The integration of polymeric patches with various types of nanoparticles (NPs) [7,21,33,34], nanosheets [28,[35], [36], [37], [38]], nanorods [27,39], metal organic frameworks (MOF) [40,41], micelles [[42], [43], [44]], and polymeric NPs [45] provided the capability to enhance the retention time of drugs, bioavailability, biodistribution, the efficiency and safety of drug delivery, stimuli responsiveness and multifunctional therapeutic demands, thus improving curative efficacy along with decreased systemic toxicity [46]. For instance, the drug-loaded nanomaterials facilitate the polymeric patches with high loading capability of drug and controllably on-demand drug release [47,48]. Because of these above unique merits, such nanomaterials integrated polymeric systems have been extensively applied for treating non-cancerous diseases, including diabetes therapy, wound healing, dermatological disease therapy, bone regeneration, cardiac repair, hair repair, obesity therapy and some immune disease therapy, realizing the more bioapplications in clinic. Despite a plethora of systematic researches and studies regarding the development of tumor theranostics are gradually increasing in number, and design of polymeric materials as delivery devices in biomedicine has also been systematically summarized in a gradually rising number of reviews [6,[49], [50], [51]]. A detailed and comprehensive overview that introduces nanomaterial integrated polymeric flexible patches in non-cancerous therapy still does not currently exist. Here, we focus on introducing the latest development of nanomaterials integrated polymeric patches for treating non-cancerous diseases (Scheme 1). Such nanomaterials that are embedded in a variety of polymeric patches applied in non-cancer therapy are in detail compared and summarized in the recent literatures (Table 1). Based on the recently regarding research, these polymeric patches with a highlight on the synthetic strategies and materials were presented and divided into the following categories: MNs, hydrogel, microsphere, microcapsule and fiber. In the following, according to the types of non-cancerous treatment, we emphatically introduced these applications in diabetes, wound healing, dermatological disease, bone regeneration, cardiac repair, hair repair, obesity and some immune diseases. Besides, we also discussed the current problems of polymeric patches as the depots in the field of biomedicine. Lastly, we give a summary and an outlook on the challenges, opportunities and perspectives of nanomaterials incorporated polymeric patches in more biomedical fields.
Scheme 1

Nanomaterials integrated polymeric patches for noncancerous disease treatment.

Table 1

Non-cancer therapeutics of nanomaterials integrated flexible polymeric patches.

TypeCharacteristics of patchNanomaterialsApplicationProperty of treatmentAnalytesRef.
MNDissolvability; biocompatibilityBlack phosphorusWound healingOxygen Responsive3T3 cells; STZ-induced diabetic mice37
MNExcellent biocompatibility; sufficient stiffnessH2O2-responsive polymeric vesicles (PVs)Diabetes therapyH2O2-responsiveHeLa cells; STZ-Induced diabetic mice75
MNHigh mechanical strength; biodegradation and long-term biocompatibilityMSC-derived exosomes; UK5099-loaded PLGA nanoparticlesHair regrowthSustained drug release capacityhuman dermal fibroblast cells, C57BL/6J mouse77
MNImproved the stiffnessGlucose responsive vesicles (GRVs)Diabetes therapyGlucose-responsive; hypoxia-sensitive; rapid responsivenessSTZ-induced diabetic mice137
MNsBiocompatibility; biodegradabilitySelf-assembled polymeric nanosized vesiclesDiabetes therapyHypoxia-sensitiveMouse islets β-cells; STZ-induced type-1 diabetic SD mice138
MNEnhanced loading capability; bioavailabilityDual-sensitive, glucose-responsive polymersomes (d-GRPs)Diabetes therapyHypoxia and H2O2 dual-sensitiveSTZ-induced type 1 diabetic C57BL/6J mice139
MNFast responsiveness; rapid hypoglycemic effect; no risk of hypoglycemiaSupramolecular polymer vesicles (PVs)Diabetes therapypH- and glucose -responsive3T3 cells; diabetic SD rats141
MNImproved mechanical strengthGOx immobilized copper phosphate mineralized particles (m-GOx); Ex4 integrated calcium phosphate (m-Ex4)Diabetes therapypH- and, glucose-responsive; closed-loop releaseC57BL/6 db/db diabetic mice142
MNImproved mechanical strengthZnO quantum dots (ZnO QDs) capped mesoporous bioactive glasses (MBGs)Diabetes therapypH- and glucose-triggered and3T3-L1 cells; diabetes SD rats143
MNRemarkable mechanical strength; slower solubility properties; high strength; slow-release performance; Strong mechanical strength; excellent swelling propertyCaCO3 microparticles (INSCaCO3 MPs)Diabetes therapySwelling-responsiveMCF-7 cells; STZ induced diabetic rats144
MNBiocompatibility; improved robustnessHRP-CaP particlesDiabetes sensingpH- and glucose-responsive; hyperglycemia sensingSTZ-induced diabetic mice145
MNFast response; excellent biocompatibility; dissolvablePolymeric vesicles (PVs)Diabetes therapyGlucose- and H2O2-responsiveSTZ-induced type 2 diabetic SD rats146
MNExcellent mechanical strength and toughnessMesoporous silica nanoparticles (MSNs)Diabetes therapyH2O2-responsiveSTZ-Induced diabetes SD rats147
MNEnhanced strengthNano-sized complex micelles (NCs)Diabetes therapyH2O2 and pH cascade-responsiveSTZ-induced type-1 diabetic SD mice148
MNImproved mechanical strengthGold nanoclusters (GNCs)Diabetes therapyGlucose-responsiveSTZ-induced type-1 diabetic SD mice149
MNHigh loading efficiency; minimal toxicityPolymer-grafted hollow mesoporous silica nanoparticles (HMSNs-PAPBA)Diabetes therapyGlucose-responsive3T3-L1 cells; STZ rats150
MNHigh biocompatibility and biodegradability; relatively low melting point; dissolving; low cost; high loading capacityPrussian blue nanoparticles (PB NPs)Diabetes therapyNIR light triggeredMuscle cells; STZ induced type 2 diabetic SD rats151
MNDissolvable; excellent flexibility and toughnessCu7S4 nanoparticlesDiabetes therapyNIR light-triggeredHeLa cells; STZ induced type 2 diabetic SD rats152
MNBiodegradable; excellent flexibility and toughness; enhanced mechanical propertyHollow mesoporous SiO2Diabetes therapyNIR-responsiveSTZ induced type 2 diabetic SD rats153
MNDissolvabilityProretinal nanoparticles (PRN)Retinoids therapySustained releaseGerman domestic pigs175
MNExcellent aqueous solubility; rapidly dissolving; good biocompatibilityBleomycin-loaded HAHypertrophic scar therapyRapid releaseHHSFs cells176
MNImproved mechanical strength; improved loading of drugHA/HP-β-CD complexHypertrophic scar therapyAccelerated self-degradationHSFbs cells, New Zealand rabbits177
MNDissolvabilityMesoporous silica-coated upconversion nanoparticles (UCNPs@mSiO2)Abnormal scar therapyGene silencingHSF cells178
MNReactive oxygen species (ROS)-responsive; excellent biocompatibility and biodegradabilityDiatomaceous earth (DE)Acne vulgaris therapyControlled and sustained drug releaseInfiltrated inflammation cells; P. acnes; P. acnes-induced mice179
MNDegradability; biocompatibilityRosi-loaded NPsObesity therapySustained releaseC57BJ/6 mice181
MNBiocompatibility; rapid DissolvabilityDNA vaccine coated PLGA-PLL/Γpga NPsEbola vaccinationSupporting the safety and immunogenicity of the vaccineHeLa cells67
MNFlexibility; dissolvabilityDNA polyplexPorcine circovirus Type 2Stronger immune response; excellent vaccine stabilitynormal mouse185
MNBiocompatibility; dissolvabilityDNA loaded RALA peptide NPsCervical cancerEnhanced immune responsesC57BL/6 mice186
MNDissolvability; sufficient mechanical strengthpOVA loaded nanopolyplexMelanomaStronger antigen-specific antibody response; enhanced antibody recall memory after challengeDC 2.4 cells; RAW 264.7 cells; C57BL/6 mic187
HydrogelHigh intrinsic bioactivity; excellent mechanical strength,Ultrathin 2D black phosphorus (BP) nanosheets; CaP crystal particlesBone-tissue regenerationMimics biological mineralizationhBMSCs cells, MC3T3 cells36
HydrogelGood biocompatibilityGold-spiked silica microrodsAnti-bacteriaPlasmonic-induced photothermal anti-bacteriaE. coli39
HydrogelGood biocompatibility; controllable porosity; degradability; swelling, rheological, mechanical, and conductive behaviorsPolydopamine-coated carbon nanotubes (CNT-PDA)Wound healingPhotothermal anti-bacteriaL929 fibroblast cells; S. aureus, E. coli; Female Kunming mice45
HydrogelExcellent biocompatibility and biological properties; improved mechanical propertiesFerritin nanocageTissue regenerationpH stimulus; less cellular toxicity; good cellular growth, controllable and sustained drug releaseNIH-3T3 cells46
HydrogelEnhanced viability; mitigated hypoxia-induced cell deathCalcium peroxide (CPO)Infarcted myocardial tissue regenerationControlled oxygen releasePhotoinitiator (Irgacure 2959)47
HydrogelImproved organization, electroactivity, mechanical integrity; improved cardiac cell adhesion, organization, and cell-cell couplingCarbon nanotube (CNT)Cardiac constructsPromote electroactive tissue repairMSCs cells48
HydrogelBiocompatible paintable conductive, strong wet adhesive propertyPolypyrrole (Ppy) nanoparticlesCardiac tissue reconstructionFaster self-degradationL929 cells, BMSCs cells; SD rats64
HydrogelExcellent operation ability; biocompatibility and most importantlyStem cell-derived exosomes (SC-Exos)Wound repairPhotoinduced imine crosslinkingNew Zealand rabbits88
HydrogelBiodegradability and biocompatibility; self-adhesive and conductiveDopamine-functionalized polypyrrole (DA−PPy)Infarcted myocardium constructionBiocleavable; mechanical supportingL929 cells, H9C2 cardiomyocytes; SD rats91
HydrogelExcellent antibacterial activitySilver nanoparticlesWound healingMetal ion induced anti-bacteriaS. aureus, E.coli155
HydrogelRelevant swelling capacity, good biocompatibility and mechanical propertiesSilver nanoparticlesWound healingpH-Responsive; metal ion induced anti-bacteriaP. aeruginosa, S. epidermidis157
HydrogelExcellent antibacterial properties; excellent injectability; biocompatibilityZinc-doped bioactive glass (ZBG)/succinyl chitosan (SCS)/oxidized alginate (OAL) composite hydrogels (Gel-ZBG)Wound healingMetal ion induced anti-bacteriaL929 cells; S. aureus, E.coli; SD rats158
HydrogelHigh antibacterial efficiencyAg/Ag@AgCl/ZnO hybrid nanostructuresWound healingReversible swelling-shrinking transition by pH; metal ion induced anti-bacteriaMC3T3-E1 cells; S. aureus, E.coli; male Wistar rats159
HydrogelGood mechanical stability; excellent tissue adhesion; self-healing propertiesPF127 nano micellesWound healingAntibiotic anti-bacteriaE. coli, S. aureus, 3T3 cells, B16F10 cells160
HydrogelStretchable compressible; self-healing injectable; pH-dependent biodegradation and release behavior,PF127–CHO micelles (Cur-PF127-CHO)Wound healingAntibiotic anti-bacteriaE. coli, S. aureus; L929 cells; hemorrhaging liver mouse161
HydrogelExcellent mechanical propertiesDiacrylated Pluronic F127 micellesWound healingMechano-responsive; antibiotic anti-bacteriaS.epidermidis, E. coli; rabbit BMSCs162
HydrogelPrevented multidrug resistance; minimized drug toxicityFe3O4@C nanoparticlesWound healingVisual and real-time monitoring of drug content; antibiotic anti-bacteriaL929 cells; S. aureus163
HydrogelInherent antimicrobia; antioxidant; cytocompatibility propertiessilver NanoparticlesWound healingAntibiotic anti-bacteriaS.aureus, P. acnes and Candida auris164
HydrogelSuperior antibacterial capacity; reduced inflammatory response; promoted angiogenesis abilityCu nanoparticles (Cu NPs)Wound healingPhotothermal anti-bacteriaNIH-3T3 cells; S. aureus and E.coli; SD rats165
HydrogelExcellent and controlled photothermal abilityOligomeric proanthocyanidins (OPC)Wound HealingPhotothermal anti-bacteria lB16F10 cells, nude Balb/c mouse; STZ diabetic C57BL/6 mouse166
HydrogelInjectable photo–cross linked; biodegradability; biocompatibility; protection of loaded drugsPLGA nanoparticlesBone tissue repairSustained releaseMSCs cells167
HydrogelImproved strength and conductivityCarbon nanotubes (CNTs)Cardiac constructsImproved cardiac cell functionsLX-2 cells; SD rats169
HydrogelInjectable; sustainable; thermoresponsiveCopper sulfide nanodotsObesity therapyNIR-II photothermal-responsivePrimary human white preadipocytes; high-fat-diet fed mice182
FiberEnhanced mechanical properties, wettability, thermal stability, biominerals deposition, and biocompatibility, proliferation and differentiation behavior2D MoS2 nanosheetsBone tissue regenerationThermal induced decompositionMC3T3-E1 cells38
FiberEnhanced cell adhesion, growth, proliferation; enhanced bioactivity, biocompatibility and osteogenic differentiationPolypyrrole nanoparticles (PPy–NPs)Bone tissue regenerationElectrical stimulationMC3T3-E1 cells118
FiberStrong biocompatibility, bactericidal, porous and mechanicallySilver nanoparticleWound healingMetal ion induced anti-bacteriaNIH3T3 cells; S. aureus, E.coli156
MicrocapsuleBiocompatibility and biodegradabilityPLGA microcapsulesTissues regenerationMechano-activationMSCs cells115
Nanomaterials integrated polymeric patches for noncancerous disease treatment. Non-cancer therapeutics of nanomaterials integrated flexible polymeric patches.

Classification of flexible polymeric patches

Currently, flexible polymeric matrix has been extensively studied in the field because of some unique outcomes, such as excellent biocompatibility, high drug loading capability, low bio-toxicity and, as well as a simple and economical production procedure. A diversity of polymers with varying performance were utilized to manufacture different flexible matrixes to achieve suitable and superior polymeric treatment modality under the relevant environment. Based on the applied morphological structure, these polymeric matrixes can be categorized into three forms: MNs patch, hydrogel patch and microsphere/microcapsules. Anything but this their ability of protecting the incorporated nanomaterials or drugs from biological and physical disruption and releasing them by dissolving, swelling or degrading, other advantages and disadvantages were compared and shown in Table 2.
Table 2

Comparison for advantages and disadvantages of different flexible polymeric patches.

Polymeric matrixAdvantagesDisadvantages
MNPrecise drug loading;High drug loading efficiency;Realizing instant transdermal drug delivery;Unique capability of swelling;Allowing attachment of drug reservoir;No measurable polymer residue leaving;Extracting the interstitial fluid from the skin and release of pre-loaded drugs;Easy remove after treatment;Treatment can be momentarily stopped;Proper biosafety and repeated useNeed more waiting-time to completely dissolve before removing the patch;Only used in epidermal disease treatmentLimited drug loading into the polymeric matrix
HydrogelHigh drug loading efficiency;Unique capability of swelling;Usually employed for sustained drug releasePolymer residues found in skin within a few days;Influence of cross-linking conditions on bioactivity of drugs;Easy leaky of drug during delivery
Microsphere/microcapsuleIncreasing drug loading efficiency through encapsulation or coating;Polymer residues found in skin within a few days;Slow self-degradation;Easy leaky of drug during delivery
Comparison for advantages and disadvantages of different flexible polymeric patches.

Microneedle arrays

Microneedle (MN) arrays are needles of 25 μm–2000 μm supported on a base or patch [52], it was first conceptualized as a non-invasive parenteral (transdermal) drug delivery system in 1971 with the first successful instance in 1998 using silicon MNs to deliver calcein [53,54]. Parenteral drug delivery methods such as MN arrays and injections offers several advantages over conventional oral drug delivery; namely the possibility of gastric irritation of some drugs [55], elimination of the drug through hepatic first-pass metabolism in the liver [56], and poor compliance of the patients [57]. Moreover, within parenteral drug delivery systems, MN arrays are preferred over injections as it does not cause bleeding, is pain-free, easy to apply, and does not generate non-ecofriendly biohazardous sharp waste [58]. MNs can be categorized into several types according to the mechanism of drug delivery [52], such as solid [[59], [60], [61]], hollow [61,62], coated [[63], [64], [65]], dissolving and hydrogel types. Usually, MNs are employed as a preprocessed stratagem, which could produce microchannels to improve drug diffusion through inserting and withdrawing the MNs on the skin. Hollow MNs were reported to demand precision microfabrication techniques for constructing an interior lumen in each needle to inject drug, and commonly were used to facilitate drug delivery under the assistance an external driving force. The coated MNs were defined due to the loading of specific drug onto the surface of solid MNs to target delivery via dip coating, layer-by-layering coating, spray coating, and roll coating. These three MNs were most fabricated by inorganic materials including silicon and stainless steel by laser cutting and chemical etching, thus, this section will describe commonly used polymeric MN materials and advances in recent MN based drug delivery systems.

Dissolving microneedles

Dissolving MNs are made of a bio-dissolvable material and generally holds the drug mixed in with the polymeric matrix, which eventually dissolves and releases the drug into the body. Such dissolving MNs are generally fabricated by pouring the polymer mixture and drug into a polydimethylsiloxane (PDMS) mold, and left to solidify, followed by a piece of adhesive on top of it as shown in Fig. 1A [66,67]. One of the most commonly used polymeric material for dissolving MNs is polyvinylpyrrolidone (PVP) due to its biocompatibility and high dissolvability [68], which has been demonstrated to be capable of delivering all sorts of drugs [58,69,70], antibodies [71] and vaccines [[66], [67], [68]], both by itself and also in conjunction with other polymeric matrices. For example, Sung et al. reported the use of PVP MNs to deliver two model drugs, AlexaFluor-488 (Alexa-488) and subsequently Cyanine5 (Cy5) contained within pH-responsive hollow polymer microspheres. The MNs were successfully applied onto rat skin without breaking, and quickly dissolved within minutes to release the first drug (Alexa 488) and depositing into the tissues (Fig. 1B) [70]. The second drug (Cy5) encapsulated in hollow microspheres was subsequently released to neighboring tissues in an acidic environment. In 2020, it was demonstrated that the addition of magnesium (Mg) microparticles in dissolving PVP MNs allows a form of active delivery without external stimulus, as the H2 gas generated act as “pumps” which enhanced the rate of delivery (Fig. 1C) [71]. By using the active delivery MNs, it was demonstrated to also be capable of delivering a macromolecule; cowpea mosaic virus (CPMV) nanoparticles for treatment of cutaneous melanoma, which was previously difficult to perform under passive delivery [66].
Fig. 1

A) Schematic Illustration of microneedles fabrication by PDMS cast molding. Reprinted with permission from Ref. [67]. Copyright 2017, Wiley. B) A schematic illustrating the design of the PVP MN arrays containing pH-responsive pH-responsive hollow microspheres (HMs) and the mechanism for delivering of two different drugs. PLGA: poly(D,L-lactic-co-glycolic acid). DiI: (1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate). Reprinted with permission from Ref. [70]. Copyright 2012, Elsevier. C) Illustration of the active delivery MN containing Mg particles, where contact with bodily fluids releases H2 gas that act as “pumps”. Reprinted with permission from Ref. [71]. Copyright 2019, Wiley.

A) Schematic Illustration of microneedles fabrication by PDMS cast molding. Reprinted with permission from Ref. [67]. Copyright 2017, Wiley. B) A schematic illustrating the design of the PVP MN arrays containing pH-responsive pH-responsive hollow microspheres (HMs) and the mechanism for delivering of two different drugs. PLGA: poly(D,L-lactic-co-glycolic acid). DiI: (1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate). Reprinted with permission from Ref. [70]. Copyright 2012, Elsevier. C) Illustration of the active delivery MN containing Mg particles, where contact with bodily fluids releases H2 gas that act as “pumps”. Reprinted with permission from Ref. [71]. Copyright 2019, Wiley.

Hydrogel microneedles

Hydrogel MNs are made of polymeric materials that are capable of forming a three-dimensional (3D) cross-linked polymeric network, resulting in a porous structure that allows it to retain water. These properties allow hydrogel MNs to deliver hydrophilic drugs after absorption of interstitial skin fluid from a reservoir or within the hydrogel, in a controlled manner by variation of its pore size [72]. Several polymeric materials have seen uses as hydrogel MNs, such as polyvinyl alcohol (PVA) [[73], [74], [75]], poly(methyl vinyl ether-maleic acid) copolymer [74], and several other homopolymers and copolymers [76,77]. One of the drawbacks was that drugs compatible with hydrogel MNs were previously limited to those stable in aqueous environments. Recently, Donnelly's group demonstrated that the use of a non-aqueous directly-compressed tablets as a reservoir could facilitate the delivery of several drugs transdermally using hydrogel MNs including amoxicillin which hydrolyses in aqueous medium, greatly expanding the possibilities of compatible drugs [74].

Hydrogel patches

Hydrogel is a three-dimensional network of hydrophilic polymers, which can imbibe and retain water in its porous structure due to cross-linking of polymer chains [[78], [79], [80], [81], [82], [83], [84]]. The use of hydrogels in biomedical applications stems from its similarity to a tissue's extracellular matrix (ECM) [85], making it an attractive biocompatible polymeric material to hold hydrophilic drugs and other biomedical applications. One of the first few studies of the biomedical application of hydrogels was the potential of acrylate polymers for cornea surgical implants in 1965 [86]. Soon after, ethylene glycol methacrylate hydrogels was tested for subcutaneous application in rats in 1967 [87], followed by a study on its diffusion of anti-tumor drugs using methacrylate hydrogels in 1974 [88]. Since then, there have been many developments in this field with different kinds of natural and synthetic materials-based hydrogels, in which the common hydrogel materials used in various recent biomedical applications will be highlighted here. Up to now, hydrogel can be categorized into natural polymer based hydrogel and synthetic polymer based hydrogel depended on the applied polymer materials. Natural polymer based hydrogel was composited of nature polymers including alginate, hyaluronic acid, dextran, and chitosan, collagen, albumin, elastin, and gelatin [[89], [90], [91], [92]]. These materials have all been developed for drug delivery applications due to their good tolerance in vivo, availability in abundance in nature, and ability to generate hydrogels via self-assembly or by cross-linking. The feature of spontaneously forming hydrogels for some natural polymers been used to construct smart delivery nanoplatforms that can be injected locally as a liquid and solidify into a hydrogel drug depot excited by the changes in the environment such as pH, temperature, or ionic composition. For this point, we will in detail introduce using gelatin-based hydrogels and hyaluronic acid-based hydrogels as examples in the following.

Gelatin-based hydrogels

Gelatin is a protein-based biomaterial which is obtained from hydrolysis of collagen, with good biocompatibility and biodegradability properties. However, it suffers from poor mechanical properties on its own without any cross-linkers. As such, gelatin is commonly used in conjunction with other compounds to optimize the mechanical features and offer additional properties [64,[93], [94], [95], [96], [97]]. One of such modification that is commonly used is gelatin methacryloyl (GelMA). GelMA was developed as a photo-crosslinkable hydrogel for creating microtissues, microfluidic devices and as a scaffold for epidermal tissue engineering. It demonstrated tunable mechanical, degradation and biological properties by variation of its methacrylation degree and hydrogel concentration [98,99]. GelMA has since been applied in all kinds of biomedical fields including drug delivery [46], cardiac patches [48], and tissue regeneration scaffolds [36,100]. Khademhosseini and the co-wokers reported an oxygen-generating calcium peroxide (CPO) incorporated GelMA hydrogel as shown in Fig. 2A [47]. The biocompatible hydrogel was able to release oxygen and relieve the metabolic stress of cardiac cells under hypoxic conditions, significantly enhancing cell viability by reducing hypoxia-induced necrosis. Recently, Xu et al. demonstrated a biodegradable conductive hybrid hydrogel containing GelMA as the scaffold and polydopamine-modified black phosphorus (BP@PDA) nanosheets as the conductive component (Fig. 2B) [100]. The conductive GelMA-BP@PDA hydrogel was able to improve the mesenchymal stem cells migration into neural-like cells owing to the assistance of electrical stimulation, opening up the possibilities of materials used in electroactive tissue engineering.
Fig. 2

A) Schematic illustration of the fabrication of GelMA hydrogels and the oxygen generation from encapsulated CPO. The GelMA hydrogels were prepared by mixing GelMA, CPO and cardiac side population cells (CSPs) via photopolymerization. Reprinted with permission from Ref. [47]. Copyright 2017, American Chemical Society. B) Illustration of the modification of black phosphorus (BP) nanosheets with polydopamine (PDA) and the incorporation of the BP@PDA nanosheets into GelMA hydrogel (GelMA-BP@PDA hydrogel). Reprinted with permission from Ref. [100]. Copyright 2020, Wiley.

A) Schematic illustration of the fabrication of GelMA hydrogels and the oxygen generation from encapsulated CPO. The GelMA hydrogels were prepared by mixing GelMA, CPO and cardiac side population cells (CSPs) via photopolymerization. Reprinted with permission from Ref. [47]. Copyright 2017, American Chemical Society. B) Illustration of the modification of black phosphorus (BP) nanosheets with polydopamine (PDA) and the incorporation of the BP@PDA nanosheets into GelMA hydrogel (GelMA-BP@PDA hydrogel). Reprinted with permission from Ref. [100]. Copyright 2020, Wiley.

Hyaluronic acid-based hydrogels

Hyaluronic acid (HA) is a polymeric glycosaminoglycan commonly found in body tissues and fluids. The abundance of HA in tissues, and possibility of chemical modifications due to the presence of easily modifiable functional groups [101], makes it an attractive material for a range of bioapplications such as drug delivery [41,102,103], cell culture and tissue engineering scaffolds [48,104] and more [97,105]. Cho and the coworkers incorporated either carbon nanotubes, polypyrrole, or both into catechol-functionalized HA hydrogels and fabricated electrically conductive hydrogels as a 3D ECM scaffold for cell culture and tissue engineering of stem-cell-mediated neuronal regeneration [104]. The same group reported that HA hydrogels modified with phenolic moieties exhibited stronger tissue adhesiveness and greater elastic modulus, which can then be transferred to an off-the-shelf form for clinical use which was previously difficult to achieve [106]. However, natural polymer exhibit some shortcomings [107]: 1) their poor solubility, especially in organic solvents, limits the processing possibilities and makes it more difficult to include water-insoluble chemotherapeutic drugs; 2) their biocompatibility necessitates great purity; 3) the lack of chemically tweaking polymer constitutions impacts critical features like drug release kinetics and degradation rate. Conversely, because synthetic polymers that used to prepare synthetic polymer based hydrogel, allow for such high levels of customization, local implants can be designed for specific applications in terms of mechanical qualities, degradation, and drug release. A large number of synthetic polymers including polyanhydrides based on sebacic and adipic acid, polyesters based on lactide, glycolide, caprolactone, and dioxanone, as well as polyamides polycarbonates, polyorthoesters, and phosphate-based polymers [[108], [109], [110]], have been used to fabricate various delivery materials. These polymers are frequently hydrophobic in nature, making them ideal for long-term delivery and internal stabilization of sensitive water-insoluble drugs. Although such synthetic materials have a disadvantage of forming acidic decomposed products, which can induce accumulation and inflammation at the implant site, this affection can be attenuated by modulation in chemical constitution and their degradation performance.

Other polymeric matrixes (microsphere/microcapsule/fiber/microchamber)

Apart from the well-studied microneedle and hydrogel matrixes, there have been other polymeric matrixes, such as microspheres, microcapsules, fibers and microchambers, which are capable or potentially capable of biomedical applications. In comparison with conventional drug administration methods, the use of polymeric matrices for drug encapsulation and releasing enable to prolong the active duration, minimize systemic toxicity, and protect the sensitive drugs from degradation. Microspheres are spherical microparticles of diameters between 1 and 1000 μm, generally made of biodegradable polymers such as poly(lactic acid) and a copolymer of lactic acid and glycolic acid, with the drugs mixed in homogeneously [111]. The drugs were released after ingestion or injection of the microsphere. Microspheres have also been demonstrated to be compatible with microneedles [69,70] and hydrogels [112]. It was also capable of being a carrier for liquid metals for cancer chemophotothermal therapy [113]. Additionally, Liu et al. prepared poly(D,L-lactic-co-glycolic acid) (PLGA) microspheres containing doxorubicin (DOX) via electrospray [114]. The microspheres have a mean diameter of 6.74 ± 1.01 μm and were applicable for intratumoral injection. The in-vitro release test indicated that 12.3% and 85.8% of DOX released on day 1 and after 30 days, respectively. A higher local drug concentration at the target lobe of the liver was also detected, indicating that the microspheres are potentially useable as a drug delivery vehicle to targeted lesions. Furthermore, microcapsules are spherical microparticles similar to microspheres, but instead of the drug mixed homogeneously, the drugs are encapsulated by a polymeric coating [115]. The release of drugs can be tailored to be in response to certain stimulus such as pH [116,117], temperature [117,118], light [119], magnetic field strength [120] and even mechanical input [121]. Also, up to today, fibers made from polymeric material have extensive uses in biomedical applications as scaffolds due to its similarity to ECM, desirable mechanical properties and possibilities for modification [122]. Fiber-like polymeric matrices have been uses in myocardial remodeling [123] and more commonly in tissue engineering and regeneration of bones [38,[124], [125], [126]], skin [127], and vascular system [128]. Beyond these patches, microchamber arrays, as one of most common polymer patches, contain individual micro-scaled voids on a flat polymeric matrix, and they are fabricated by microfabrication techniques such as multistep lithography or layer-by-layer assembly processes [129,130]. Microchamber arrays are advantageous on their simple and low-cost processes using a universal mold and under arbitrary conditions. Similar with the other polymeric matrices, microchamber arrays can combine the stimuli-responsive functionalities, e.g., pH, light, temperature, or ultrasound, to control their shell permeability and drug releasing rate for site-specific release-on-demand [[131], [132], [133], [134]].

Non-cancer therapy of nanomaterials incorporated polymeric patches

With the rapid development of global socioeconomics, a growing number of diseases have been found to become a global threat to human health, leading to the influence of human life. In addition to cancer that most is related to its occurrence and metastases [135,136], other noncancerous diseases, including diabetes [137], infected wound [138], cartilage damage [139], cardiac decease [140], obesity [141] and dermatological disease [142], have also dramatically increased and become the most serious public health problems in the 21st century. Within this context, it is an urgent requirement to explore effective treatments for these non-cancerous diseases. Currently, various treatments like surgery, CHT, RT, PTT, PDT, CDT, immunotherapy, have been developed as the main methods. Besides this, appropriate therapeutic nanoagents are highly desirable to been designed for enhanced efficiency and inhibition of diseases.

Diabetes therapy

Diabetes mellitus is a well-known chronic metabolic disease, which mainly depended on the failed blood glucose levels (BGLs) regulation. Generally, the traditional approach of curing patients suffered from type 1 and type 2 diabetes is to control normoglycemia level through applying insulin pumps or injecting insulin along with monitoring of glycemic levels. Such self-treatment with pain and nconvenience is usually not feasible to control glucose, increasing the biofouling risk in body. To avoid the aforementioned problems, a wide range of glucose-responsive insulin-releasing nanosystems have been developed to allow controllably insulin release for mimicking the β-cells. In view of the enzymatic reaction: , glucose could be oxidized to generate H2O2 and gluconic acid under catalysis of glucose oxidase (GOx) enzyme. Such GOx-catalyzed reaction could be accelerated by consuming O2, local hypoxia and decreasing pH in local microenvironment. In light of this, pH-, hypoxia-, H2O2- and other-responsive nanoplatforms have been extensively explored to construct controlled insulin delivery systems with fast response, high loading capability and superior biocompatibility though intercalating into flexible polymeric patch.

Hypoxia-responsive polymeric patch for diabetes treatment

By virtue of local hypoxia generation from O2 consumption in the GOx-catalyzed reaction, Gu et al. designed glucose responsive vesicles (GRVs) and incorporated a painless MN patch to establish a novel glucose-responsive insulin delivery device [143]. The insulin and GOx enzyme co-loaded GRVs were responsive to hypoxia owing to self-assembly from hypoxia-sensitive 2-nitroimidazole conjugated HA (NI-HA). With the enzymatic oxidation of glucose, hypoxic microenvironment was formed to induce the reduction of hydrophobic NI to hydrophilic 2-aminoimidazoles by bioreducing agents, leading to GRVs dissociation and insulin release. When applied in type 1 diabetes induced animal model, this smart insulin delivery system could effectively regulate the BGL. This work firstly introduced to control insulin release activated by hypoxia, and its rapid responsiveness exhibited the potential to prevent hyperglycemia and hypoglycemia in diabetes therapy. Based on this concept, this group also provided “glucose-signal amplifiers” (GSAs) embedded MNs system for glucose-responsive regulation of BGLs [144]. Accounting for the hydrophobic-to-hydrophilic conversion of NI under hypoxia condition, GSAs were self-assembled by NI-HA and simultaneously entrapped GOx, α-amylase (AM) and glucoamylase (GA). This design of “amplifier” is the first time to amplify the physiological signal for effectively transporting signal and mimicking the secretion of insulin from the β-cells. Inspired by this work, hypoxia and H2O2 dual-sensitive polymersome based vesicles integrated MNs were designed to regulate the BGLs (Fig. 3) [145]. The amphiphilic polymer composed of PEG) and NI modified polyserine via a thioether moiety can encapsulate insulin and GOx by self-assembly (Fig. 3A). On account of the similar mechanism for conversion of hydrophobic IN to hydrophilic under hypoxia and introducing thioether as H2O2 sensitive moiety, such smart insulin patch was proved to high effectively regulate the BGLs in the diabetic mice with minimal side effect in regard to inflammation (Fig. 3B). This report offers new direction to design the dual-sensitive nanosystems for high oxidative stress and hypoxia related therapy.
Fig. 3

Illustrative fabrication of hypoxia and H2O2 dual-sensitive polymersome-based vesicles (d-GRPs) loading MN patches, A) Mechanism of preparing d-GRPs coated by PEG-poly(Ser-S-NI); B) scheme for descripting local inflammation induced by non–H2O2–sensitive GRP-loaded MN patch, and d-GRP-loaded MN patch for in vivo insulin delivery under a hyperglycemic state. Reprinted with permission from Ref. [145]. Copyright 2017, American Chemical Society.

Illustrative fabrication of hypoxia and H2O2 dual-sensitive polymersome-based vesicles (d-GRPs) loading MN patches, A) Mechanism of preparing d-GRPs coated by PEG-poly(Ser-S-NI); B) scheme for descripting local inflammation induced by non–H2O2–sensitive GRP-loaded MN patch, and d-GRP-loaded MN patch for in vivo insulin delivery under a hyperglycemic state. Reprinted with permission from Ref. [145]. Copyright 2017, American Chemical Society. In the past decades, a large variety of pH-responsive amphiphilic polymers have been broadly investigated for controlled drug delivery in the therapeutic application. Recently, pH-responsive a composite enzyme layer (CEL) was designed to coat mesoporous bioactive glass nanoparticles (BGNs) loaded with insulin, and subsequently incorporated into polymeric MNs [146]. In this case, the as-formed CEL composited of GOx, CAT and polyethyleneimine (PEI) was served as glucose-sensitive layer and ‘gatekeeper’ for avoid the insulin leakage from BGNs. The pH decrease caused by the catalytic reaction by GOx/CAT destroyed the CEL structure, resulting in the insulin release, rendering the BGLs regulation. Alternatively, Cen et al. integrated pH and glucose-responsive supramolecular polymer vesicles (PVs) used as the depot of insulin and GOx with transcutaneous MNs [147]. The enzymatic catalysis of GOx led to the declined glucose level and the decreased local pH, triggering the disassociation of PVs, contributing to the fast release of loaded insulin. In addition to pH-responsive organic micelle for diabetes treatment, pH sensitive inorganic nanomaterials have also been employed to integrate with polymeric patch for control BGLs in diabetes. In a simple paradigm, pH-responsive mineralized calcium phosphate NPs immobilized with Exendin-4 (Ex4) and copper phosphate NPs encapsulated win GOx were both integrated with flexible polymeric MN patch [148]. Noted that the embedded mineralized particles enabled the improved mechanical strength of MNs for painless and non-invasive transdermal administration while skin penetration. Under acidic condition, the dual mineralized NPs could spontaneously dissolve to separately release GOx for regulating BGLs and Ex4 for diabetes therapy. Such glucose-responsive and closed-loop release system significantly enhanced Ex4 therapeutic efficiency, providing the insight of developing an effective approach for BGLs regulation in type 2 diabetes (T2D) therapy. Furthermore, Jiang and colleagues incorporated and mesoporous bioactive glasses (MBGs) loaded with insulin/GOx/CAT and capped with ZnO quantum dots (ZnO QDs) into polymeric MNs [149]. In the MBGs based MNs system, the nanopores of MBGs were sealed by insulin and GOx/CAT, and subsequently caped by pH-sensitive ZnO QDs via electrostatic interaction. Under the low pH microenvironment, insulin and GOx/CAT were gradually released by decomposition of ZnO QDs, allowing lower hypoglycemia risk. In another research work, insulin-loaded CaCO3 microparticles (INS–CaCO3 MPs) were integrated with polymeric MNs [150]. The low local pH led to the decomposition of INS-CaCO3 MPs, thus triggering the insulin release, allowing for glucose regulation. As another attractive paradigm, mimic multi-enzyme metal-organic framework (MOF) was deigned together with ethylene diamine tetraacetic acid (EDTA)-modified SiO2 nanoparticles (EDTA-SiO2 NPs) to embed into polymeric MNs (Fig. 4A) [40]. In this work, acid-sensitive MOF was engineered as the depots of insulin, GOx and Co2+ to develop a catalase-mimic vehicle. Therein, GOx in the MOF facilitated to reduce glucose, decrease local pH and generate H2O2. Under lower local pH, MOF could be decomposed to release insulin, and Co2+ from MOF could consume the generated H2O2, as well as extra Co2+ was chelated ETDA-SiO2 NPs and eliminated along with MNs out. In short, such mimic multienzyme MOF-based MNs were proved to highly promising for diabetes treatment. Lately, pH responsive and HRP (horseradish peroxidase) caped calcium phosphate (CaP) NPs, 3,3′,5,5′-tetramethylbenzidine (TMB) and GOx was combined to incorporate into MNs for colorimetric sensing BGLs [151]. On the basis of the GOx-catalyzed reaction, the increased local acidity caused the CaP NPs decomposition, triggering HRP release. Such HRP could catalyze the reaction between the generated H2O2 and TMB, resulting in displaying color change at different BGLs.
Fig. 4

A) Schematic description of synthesizing Mimic multi-enzyme ins/GOx@Co-ZIF-8 and MOF-based MNs for glucose-mediated transdermal insulin release, (a1) Illustration of preparing multi-enzyme ins/GOx@Co-ZIF-8, (a2) schematic depiction of MOF-based MNs for transdermal insulin release. Reprinted with permission from Ref. [40]. Copyright 2020, American Chemical Society. B) Schematic illustration of vesicles for glucose mediated insulin delivery, (b1) illustrative formation and degraded mechanism of mPEG-bP(Ser-PBE), (b2) schematic description of the self-assembly of PVs loaded with insulin and GOx and their dissociation to release insulin under a hyperglycemic condition, (b3) illustrative diagram of PVs-based MNs patches for smart insulin delivery in a mouse model of type 1 diabetes. Reprinted with permission from Ref. [75]. Copyright 2017, American Chemical Society. C) Scheme of H2O2 and pH -responsive NC-loading MN-array patch for in vivo insulin delivery, (c1) illustrated description of preparing H2O2 and pH cascade-responsive NC-loading MN-array patch, (c2) schematic route for polymer synthesis, (c3) illustration of NC-containing MN-array patch for in vivo insulin delivery under a hyperglycemic state. Reprinted with permission from Ref. [154]. Copyright 2018, Wiley.

A) Schematic description of synthesizing Mimic multi-enzyme ins/GOx@Co-ZIF-8 and MOF-based MNs for glucose-mediated transdermal insulin release, (a1) Illustration of preparing multi-enzyme ins/GOx@Co-ZIF-8, (a2) schematic depiction of MOF-based MNs for transdermal insulin release. Reprinted with permission from Ref. [40]. Copyright 2020, American Chemical Society. B) Schematic illustration of vesicles for glucose mediated insulin delivery, (b1) illustrative formation and degraded mechanism of mPEG-bP(Ser-PBE), (b2) schematic description of the self-assembly of PVs loaded with insulin and GOx and their dissociation to release insulin under a hyperglycemic condition, (b3) illustrative diagram of PVs-based MNs patches for smart insulin delivery in a mouse model of type 1 diabetes. Reprinted with permission from Ref. [75]. Copyright 2017, American Chemical Society. C) Scheme of H2O2 and pH -responsive NC-loading MN-array patch for in vivo insulin delivery, (c1) illustrated description of preparing H2O2 and pH cascade-responsive NC-loading MN-array patch, (c2) schematic route for polymer synthesis, (c3) illustration of NC-containing MN-array patch for in vivo insulin delivery under a hyperglycemic state. Reprinted with permission from Ref. [154]. Copyright 2018, Wiley. As previous demonstrated, the generated H2O2 from GOx-catalyzed reaction is elevated contributing to the concern of long-term biocompatibility and the problems of deactivating GOx. With the aim of avoiding the negative effects and supplying O2 for improving catalytic activity of GOx, CAT and CAT related enzyme-mimicking nanomaterials have been employed in the diabetes treatment. Beyond that, the engineered H2O2-responsive nanoplatforms were reported to be as an alternative way for insulin delivery. In a typical example, Gu et al. created H2O2-responsive polymeric vesicles (PVs) integrated transcutaneous MN delivery device though cross-linked HA as the polymeric matrix [75]. The PVs was fabricated through self-assembly of polyserine (mPEG-b-P(SerPBE)) conjugated with phenylboronic ester (PBE) (Fig. 4B-b1), as well as loaded with insulin and GOx. With the H2O2 generation via GOx catalyzed reaction, the PBE side chains was broken away from copolymer mPEG-b-P(Ser-PBE), resulting in dissociation of PVs, enabling the fast release of insulin (Fig. 4B-b1 and -b2). While applied in diabetic mice, the concentrated glucose under the hyperglycemic condition prompted PVs to release insulin with rapid responsiveness for regulating BGLs (Fig. 4B-b3). Once BGLs declined to normoglycemic state, the insulin release would gradually stop, thus circumventing hypoglycemia risk. In consideration of PBE as H2O2-sensitive block, Liu and co-worker synthesized a triblock copolymer including poly(ethylene glycol), poly(phenylboronic acid) as glucose-sensitive block, and poly(phenylboronic acid pinacol ester) as H2O2-sensitive blockas, which was self-assembled to form PVs [152]. The PVs loaded with insulin and GOx were integrated with polymeric MNs for transcutaneous delivery. Under hyperglycemic states, the basal insulin release enabled the elevated glucose, which would produce H2O2 through the catalytic function of GOx. The generated H2O2 further led to destroy the chemical links of phenylboronic acid pinacol ester group, completely releasing insulin. Except this, H2O2-responsive PBE group was modified on the surface of mesoporous silica nanoparticles (MSNs) via a host-guest complexation with a-cyclodextrin (a-CD). Such MSNs were further encapsulated in to MN together with insulin and GOx to form a glucose-mediated MN delivery device [153]. Though the aforementioned mechanism, H2O2 originated from GOx-catalytic reaction led to break the PBE link, destroying the disassembly on the surface the drug-loaded MSNs, finally triggering release of the preloaded insulin. Recently, a H2O2 and pH cascade-responsive nano-sized complex micelles (NCs) integrated MN system was constructed for transcutaneous insulin delivery by Gu's group (Fig. 4C) [154]. Such NCs were self-assembled from positively charged mPEG-P(DMAEMA-PBA) that was comprised of amphiphilic copolymer poly(ethylene glycol)-(2-(dimethylamino)ethyl methacrylate) (mPEG-P(DMAEMA)) and the modified 4-(bromomethyl) phenylboronic acid (PBA). GOx and insulin were successively entrapped into degradable NCs to form GOx-NCSs and Ins-NCs, which were both further embedded into polymeric MNs together with catalase nanogel (CAT-NG). Under a hyperglycemic state, due to enzymatic functions of GOx and CAT, the low local pH and generated H2O2 caused trigger the rapid and safe release of insulin, thus enabling the effective control of BGLs.

Glucose/NIR light/ultrasound-responsive polymeric patch for diabetes treatment

In view of the related reports and the GOx catalytic reaction, glucose is the direct and major factor for self-regulation of BGLs in diabetic patients. Lei et al. designed glucose-responsive gold nanoclusters (GNCs) incorporated MN patch for responsive and transdermal insulin delivery [155]. With the modification of phenylboronic acid-derived molecules, GNCs as the nanocarriers possessed extremely high loading capacity of insulin. Under hyperglycemic condition, insulin was effectively and rapidly released from GNCs due to the stronger binding capability of glucose with diol units on phenylboronic acids than that of insulin. Lately, glucose-responsive poly(3-acrylamidophenylboronic acid) (PAPBA) was designed to decorate hollow mesoporous silica nanoparticles (HMSNs), which was integrated with MNs to form a transcutaneous delivery system [156]. At a typical hyperglycemic level, the grafted PAPBA polymer as gatekeeper of metformin loaded HMSNs was protonated to open the mesopores of the metformin release, achieving the effective BGLs regulation. Apart from the issue that is related to GOx catalytic reaction, some unique strategies used in drug delivery system that are the remotely controllable release of drug have also been employed for diabetes management, such as NIR light, ultrasound. In a simple paradigm, Jiang and collogues incorporated prussian blue nanoparticles (PB NPs) and metformin into dissolving MNs patch using polycaprolactone (PCL) as polymeric matrix [157]. Under NIR light irradiation, PB NPs with photothermal effect produced heat, which could melt PCL polymer, thus enhancing the mobility of polymer chains, allowing for the metformin release. Similarly, they utilized Cu7S4 nanoparticles as the photothermal agents, metformin as the hypoglycemic drug and LA/PCL as the MN arrowheads to construct NIR responsive MN delivery system for controlling the BGLs [158]. In another design from same group, hollow mesoporous SiO2 load with metformin was functionalized with polydopamine (PDA) as the photothermal agent and lauric-acid as the phase change material, which was further embedded into MN to form a NIR-responsive polymeric MN device [159]. When inserted into skin, the LA would melt on account of photothermal effect of PDA with NIR irradiation, leading to the metformin release. Besides those, insulin-loaded PLGA nanocapsules were embedded into chitosan microgels to construct an ultrasound-responsive delivery system [160]. With the ultrasound treatment, the microgels could rapidly respond to release insulin, effectively achieving BGLs control in a pulsatile, localized, and noninvasive manner.

Wound healing

It was acknowledged that the most common therapy technique of epidermal disease including melanoma, diabetes is surgical resection in the clinic, which was accompanying with the package on the wound with bandages, cotton wool, and gauze. While such method could make the large wound difficult to heal owing to the infection of diabetic wounds and the recurrence of cancer. In order to achieve the enhancement in the healing efficiency of infected wound, it emerged to be desirable for developing various dressings like flexible polymeric matrix with multifunctional characters and antibacterial capabilities to promote wound-healing. Recently, an increasing number of nanoplatforms with various therapeutic properties have been extensively expanded to optimize wound regeneration with high efficiency through combing with dressings.

Meal ion induced wound healing

Some common metal based nanoparticles were reported to release the corresponding metal ions for application in wound healing attributed to their excellent antibacterial activity and the ability of promoting fibroblasts generation. Therein, silver nanoparticles (Ag NPs) were extensively studied as antibacterial agents through producing physical damage to the cell membrane, generating ROS, and inflicting the dysfunction of key components following by the release of Ag+. For example, Ag NPs and Ag NP/clay/activated carbon biocomposites were synthesized by green chemistry approach to intercalate into PVA hydrogel patches (Ag NP-HP and Ag NP-Bc-HP) [161]. Such Ag NP-HP and Ag NP-Bc-HP exhibited good antibacterial activity with the minimum inhibitory concentration (MIC) of 25 μg/mL and 12.5 μg/mL for Staphylococcus aureus as well as 3.13 μg/mL and 6.3 μg/mL for Escherichia coli, respectively. The highly healing efficiency of wound was demonstrated through fixing such patches in wound incision on the dorsal skin of these rabbits, proving the hydrogel patches to be a promising candidate for wound healing. Similarly, Ag NPs was applied to functionalize with a porous polyacrylonitrile (PPAN) membrane under the assistance of mussel-inspired polydopamine (PDA) to form nanofiber patches [162]. Taking advantages of Ag NPs and PDA, hydrophilicity, mechanical properties and antibacterial activity of such patches were greatly improved and endowed, successfully realizing their wound-healing of such nanofibers. Additionally, a sensitive pH-responsive hydrogel patches integrated with Ag NPs were built for controlled and pH-triggered release [163]. Particularly, with the change of pH from acidic to alkaline, Ag+ from Ag NPs was substantially increased. In vitro antibacterial studies of this hydrogel patch showed effective elimination of bacteria, indicating its potential as a novel nanoplatform to heal infected wound. Except for Ag NPs, ZnO nanoparticles (ZnO NPs) were also applied for wound healing to improve the generation of fibroblasts, thus inducing the proliferation and differentiation into myofibroblasts in wound. In a simple but creative paradigm, Hong et al. recently designed zinc-doped bioactive glass (ZBG)/succinyl chitosan (SCS)/oxidized alginate (OAL) composite based hydrogels (Gel-ZBG) for improved wound repair [164]. Within this hydrogel patch, Schiff-based linkages were introduced for proliferation of cells in wound location, Zn2+ released from ZBG and amino groups from SCS endowed the composite hydrogels with superior antibacterial features, simultaneously Si4+ and Ca2+ released from hydrogels also could stimulate fibroblasts for angiogenesis and wound closure. Further, epidermal growth factor (EGF) was chosen to load into hydrogel for enhancing tissue remodeling and cell proliferation in the wound bed. All in all, such design provided a promising nanoplatform for wound healing. For a more effective paradigm, in combination of advantages of Ag+ and Zn2+ in wound healing, Wang et al. fabricated Ag/Ag@AgCl/ZnO hybrid nanostructures to embed into a hydrogel to form the nanoparticles integrated hydrogel patch for improving wound healing and mitigating bacterial infection using a simple two-step technique (Fig. 5A) [165]. In particular, the Ag/Ag@AgCl nanostructures were firstly synthesized by assembling in the hydrogel though an ultraviolet light chemical reduction and ZnO nanostructures were subsequently embedded into the hydrogel via NaOH precipitation. Within the hydrogel patches, The Ag/Ag@AgCl nanostructures could produce the increased ROS via activation of the visible light irradiation, leading to the significant enhancement of antibacterial and photocatalytic activity from ZnO. Due to the great photogeneration of ROS, such hydrogel patch with a rapid sterilization could induce the mortality rate of 95.95% for E. coli and 98.49% for S. aureus, thus facilitating the wound healing. Besides, this hydrogel system could afford to controllably and sustainably release Ag+ and Zn2+ through the reversible swelling-shrinking transition of hydrogel stimulated the pH change in biological microenvironment. Such release of Ag+ and Zn2+ was responsive to the immune function to generate a plenty of white blood cells and neutrophils that were 2–4 times compared with that of the control, thus resulting in synergistically inhibiting bacteria and accelerating wound healing.
Fig. 5

A) Illustrative description of Ag/Ag@AgCl/ZnO hybrid nanostructures embedded hydrogel and the mechanism for wound healing by photo-inspired antibacterial. Reprinted with permission from Ref. [165]. Copyright 2017, American Chemical Society. B) Schematic illustration of hydrogel-functionalized textiles for optical screen of drug release and wound healing, (b1) preparation process of thermochromic hydrogel-functionalized textiles and the principle of drug release, (b2) optical photos of hydrogel-functionalized textiles with antibiotic loading or release. Reprinted with permission from Ref. [169]. Copyright 2019, American Chemical Society. C) Schematics of OPC-embedded hydrogel scaffolds for wound healing and melanoma therapy. Reprinted with permission from Ref. [172]. Copyright 2020, American Chemical Society. D) Scheme of NIR responsive separable MNs encapsulated with BP QDs and oxygen carrying Hb for wound healing. Reprinted with permission from Ref. [37]. Copyright 2020, American Chemical Society.

A) Illustrative description of Ag/Ag@AgCl/ZnO hybrid nanostructures embedded hydrogel and the mechanism for wound healing by photo-inspired antibacterial. Reprinted with permission from Ref. [165]. Copyright 2017, American Chemical Society. B) Schematic illustration of hydrogel-functionalized textiles for optical screen of drug release and wound healing, (b1) preparation process of thermochromic hydrogel-functionalized textiles and the principle of drug release, (b2) optical photos of hydrogel-functionalized textiles with antibiotic loading or release. Reprinted with permission from Ref. [169]. Copyright 2019, American Chemical Society. C) Schematics of OPC-embedded hydrogel scaffolds for wound healing and melanoma therapy. Reprinted with permission from Ref. [172]. Copyright 2020, American Chemical Society. D) Scheme of NIR responsive separable MNs encapsulated with BP QDs and oxygen carrying Hb for wound healing. Reprinted with permission from Ref. [37]. Copyright 2020, American Chemical Society.

Antibiotic induced wound healing

Besides these, modern medicine that is dependent on antimicrobial agents including antibiotics is also reported to be an alternative strategy to prevent wound infection through destroying pathogens or inhibiting their growth. Controllable site specific delivery of antimicrobial agents provided the enhanced efficiency of wound healing accompanying with fewer side effects by increasing target site concentration. Lately, an increasing number of antimicrobial loaded wound dressings have developed for effective wound-management. Especially, a series of F127 based self-healing injectable micelle/hydrogel composites were designed as dressing for wound healing through loading a wide range of antibiotic drug including curcumin and paclitaxel (PTX) [[166], [167], [168]]. Such hydrogel patches with self-healing and excellent mechanical property could be biodegradable to controllably release these drugs triggered by pH and mechanics, thus offering the potential as a dressing for improving joints skin wound healing. In addition, it has received much popularity to introduce on-demand released systems for real-time monitoring of drug dosage and effectively healing on wound with enhancing treatment efficiency and reduced inverse affect. For an alternative typical paradigm, One-dimensional, chainlike photonic crystal structure (1D PCs) based on Fe3O4@C nanoparticles were fabricated to intercalate into poly(N-isopropylacrylamide-co-acrylic acid) (P(NIPAM-AAc)) hydrogel-functionalized textiles to form a novel wound patch (Fig. 5 B-b1) [169]. Such wound patch exhibited on-demand drug release accompanying with visual real-time identifying of drug content. Particularly, with the increased content of hydrophilic comonomer acrylic acid (AAc) introducing to store the drug, the lower critical solution temperature (LCST) of PNIAPM was adjusted to 40 °C, realizing the mild thermal stimulated and on-demand drug release. Fe3O4@C nanoparticles were embedded into PCs with the assistance of uniform magnetic field, causing the lattice spacing of PCs. Therein, on account of the variation of the lattice spacing (d) in PCs with the contraction and expansion of hydrogels, the color of such hydrogel-functionalized textiles made a difference, displaying the content of drug uptake or release from hydrogels (Fig. 5 B-b2). Due to the presence of fabric matrix, the hydrogel wound dressings avoided holistic breaking and falling off when overstretched. In vivo results demonstrated that the Fe3O4@C nanoparticles assembled hydrogel-functionalized textiles exhibited wound-healing effects and excellent antibacterial properties. Alternatively, antibiotics were applied for enhanced wound healing in combination with Ag NPs. For example, Ag NPs were synthesized using aqueous curcumin: hydroxypropyl-β-cyclodextrin complex and was loaded into bacterial cellulose hydrogel with moist wound-healing features, forming novel dressings with high cytocompatibility and antimicrobial activity against wound-infecting pathogenic microbes [170].

Photothermal induced wound healing

Considering potential advantage of PTT to induce minimal damage and high penetration of tissue triggered by NIR light, a large variety of photothermal nanoagents have been extensively exploited for wound healing application, while few studies focused on photothermal film (dry-type patch). Thus, in one design, plasmonic-induced photothermal cellulose-patch was fabricated as armored golden E. coli (AGE) microrods via fixing the hollow and spike-like gold nanostructures (Au NS) modified silica microrods on a unicellular organism [39]. Within this cellulose-patch, unicellular organism referred to as a framework, and silica microrods decorated with Au NS acted as plasmonic NPs, endowing it with excellent photothermal property with high photothermal conversion efficiency. Under NIR irradiation in a very short time, the surface temperature of such patch quickly increased to 264 °C, leading to superior desalination and sterilization, which showed the possible applicability for wound healing. As another typical plasmonic NPs, N,N-bis(acryloyl)-cystamine (BACA)-chelated Cu nanoparticles (Cu NPs) were applied to construct the composite hydrogel with methacrylate-modified gelatin (Gel-MA) via radical polymerization with a photoinitiator [171]. Due to localized surface plasmon resonance (LSPR) effect of Cu NPs, such composite hydrogel patch was endowed with superior photothermal effect, resulting in predominant antibacterial efficacy against S. aureus and E. coli bacteria. Simultaneously, under NIR laser irradiation, heat produced from Cu NPs facilitated the rapid release of Cu2+, triggering the fibroblast proliferation with no inflammatory responses. Such aforementioned synergistic effect providing the significantly accelerated would-healing with improved angiogenesis ability, prominent antibacterial effect, and decreased inflammatory response. Besides for plasmonic NPs as traditional photothermal nanoagents, other inorganic nanomaterials have also be considered as attractive photothermal dressings for enhancing antibacterial activities during infected wound healing. In a recent example of this, novel hydrogel scaffolds were fabricated to comprise of calcium silicate nanowires (CS), sodium alginate (SA), and oligomeric proanthocyanidins (OPC) enriched with flavonoids through a 3D printing method (Fig. 5C) [172]. Within such hydrogel scaffold, its superior and controlled photothermal effect were endowed by OPC due to grape-seed extracts, its rheological feature was varied with OPC amounts and irradiation time of NIR laser, as well as its compressive mechanical property could be regulated by different durations of NIR laser irradiation. Especially, under controlled NIR laser irradiation, OPC-containing hydrogel scaffolds could produce high heat and release metal ions like Si4+, Ca2+. Such synergic effect effectively induced the inhibition of melanoma-tumor growth and obviously improved the skin regeneration and angiogenesis of tumor-caused and chronic wounds, indicating this great potential of such NIR laser stimulative hydrogel scaffold in melanoma therapy and wound healing. Additionally, the combination of the PTT and antibiotic was also recently studied for promoted wound healing. For example, Guo et al. employed polydopamine-coated carbon nanotubes (CNT-PDA) to integrate with gelatin-grafted-dopamine (GT-DA) to fabricate GT-DA/chitosan/CNT composite hydrogels with conductive, antioxidant, adhesive and antibacterial properties via an oxidative coupling reaction of catechol groups based on a H2O2/HRP catalytic system [45]. For this design, the antibiotic doxycycline and CNT-PDA was respectively embedded into the hydrogels to endow them with antimicrobial activity and photothermal effect for effectively treating infected wound. In vitro data demonstrated such hydrogels were promising to be as multifunctional bioactive dressings for greatly healing wounds infected by bacteria.

Oxygen facilitated wound healing

To the best of our knowledge, oxygen played an important role in the process of wound healing through facilitating tissue remodeling and cell proliferation. Thus, to enhance the healing efficiency of wound, a wide diversity of oxygen carriers with good biocompatibility, flexibility and high oxygen-loading efficiency have been explored in the past few decades. Flexible polymeric matrixes, as common “drug” carriers, have been greatly studied to efficiently heal wound through directly inserting the deep parts of the skin in combination with integrating different NPs. Lately, separable responsive MNs integrated with black phosphorus quantum dots (BP QDs) and protein hemoglobin (Hb) was fabricated to carry oxygen and NIR-controlled oxygen delivery for wound healing, as shown in Fig. 5D [37]. In general, MNs were constructed of two parts: gelatin methacryloyl (GelMA) as the tip materials and polyvinyl acetate (PVA) as the backing layer, which were subsequently loaded with BP QDs and Hb. Based on fast dissolvability of PVA, the backing layers were soon disappeared and biocompatible tips were stayed inside the skin when applied to skin. Taking advantage of photothermal effect form BP QDs and the reversible oxygen-binding feature from Hb, the local temperature in skin could increase to induce the reduced binding capability between Hb and oxygen under the irradiation of NIR light, further gradually leading to responsively release oxygen, thus realizing the efficient wound healing. Of note, it is crucial to identify the highly efficient healing ability of BP QDs integrated MNs was demonstrated on treating the cutaneous wounds of a type I diabetes on rat model. Such design indicated the potential value of such responsive NPs intercalated MNs in wound healing and other bioapplications.

Bone and cartilage regeneration

Except for the application in diabetic therapy and wound healing, flexible polymeric matrix hold the great potential for other diseases treatment including bone regeneration, cardiac constructs, hair growth, etc. owing to its good biocompatibility, relatively safe property and inherent minimal invasiveness. The incorporation of NPs into the polymeric matrix could lead to improve the mechanical and electrical features for obtaining satisfactory therapeutic efficacy. Thus, NPs intercalated flexible polymeric matrix has been broadly studied for improved therapy of treating these non-cancerous diseases. Currently, bone tissue engineering has been mainly reported to explore novel active biomaterials that could induce the functional and structural interface with bone defect for remodeling the damaged tissues. Currently, a huge range of soft polymer materials have been widely applied for bone tissue engineering ascribed to biomineralization, biodegradability, biocompatibility, and osteogenic differentiation. The insertion of NPs simultaneously could endow polymeric matrix with comprehensive mechanical properties for improving bone and cartilage regeneration. To the best of our knowledge, polymeric hydrogels with self-healing properties have recently been received tremendous attention in tissue engineering applications because of the similar structure to the natural extracellular matrix. Alternatively, it is widely acknowledged that the two-dimensional (2D) nanomaterial as a promising reinforcement material was commonly incorporated into polymeric matrix for next-generation bone tissue engineering application. As an example, Ding and his co-workers fabricated nanoengineered (NE) hydrogels with biomimetic extracellular matrices (ECM) microenvironments by incorporating ultrathin 2D black phosphorus (BP) nanosheets into the DN hydrogels with multiple functions for tissue regeneration (Fig. 6A) [36]. Above all, this work firstly introduced poly(2-hydroxyethylacrylate) (PHEA), poly(N,N-dimethyl acrylamide) (PDMA), or polyacrylamide (PAM) as the first ductile network, and chitosan methacrylate (ChiMA), alginate methacrylate (AlgMA), or gelatin methacrylate (GelMA) as the second brittle network to form the combinatorial screening double network (DN) hydrogels with tunable strength through physically and chemically crosslinked networks via photopolymerization (Fig. 6A-a1). Notably, the as-chosen second brittle network was composed of methacrylate decorated natural-polymers originated from ECM molecules. Subsequently, synthetic exfoliated BP nanosheets were incorporated into various DN hydrogels with tunable toughness and high mechanical strength using a combinatorial screening strategy. It was noteworthy that the introduction of BP nanosheets facilitated the NE hydrogels for excellent bioactivity and exceptional mineralized matrix formation ability, which was beneficial for mediating cell fates and tissue regeneration of NE hydrogels. Beyond that, CaP nanocrystal in NE hydrogels were quickly generated under weak alkaline conditions with the assistance of BP nanosheets, thus which could mimic biological mineralization as the capability of CaP mineralization climbed in the NE hydrogels (Fig. 6A-a2). Collectively, the combination of bioactive components with excellent mechanical features improved the osteoblastic cell activity and bone regeneration in the NE hydrogels, exhibiting the great potential for regeneration of load-bearing tissues. Similarly, gelatin methacryloyl (GelMA) hydrogel matrix was applied to fabricate the physically and covalently conjugated nanocage-laden hydrogels through incorporating ferritin and equivalent apoferritin as nanocages [46]. Such hydrogels could release the loaded fluorescein isothiocyanate (FITC) by pH stimulus, showing the promising materials for bone repair engineering application. Lately, an acellular tissue patch (EHG) was explored using photo-induced imine crosslinking hydrogel glue with biocompatibility, superior operation ability and cartilage-integration as an exosome scaffold for cartilage regeneration [94]. Hereinto, such EHG was observed to exhibit the following features: the ability to positively adjust chondrocytes and hBMSCs in vitro with reserving SC-Exos; improving the capability of cell deposition at cartilage defect sites through integrating with native cartilage matrix which thus facilitating the enhancement of cartilage defect repair. This result indicating the potential of EHG tissue patch as cell-free scaffold material for future wound repair. Also, KGN-loaded PLGA NPs was developed to integrate with m-HA hydrogel for facilitating hyaline cartilage and subchondral bone tissue repair [173].
Fig. 6

A) Schematic illustration of BP NSs incorporated hydrogels for upregulated bone formation, (a1) illustrative preparation of double network (DN) hydrogels with different strength, (a2) bioactive nanoengineered (NE) hydrogels composition of black BP NSs and CaP matrix formation in DN hydrogels for bone regenerations. Reprinted with permission from Ref. [36]. Copyright 2019, Wiley. B) Scheme for preparing a conductive and adhesive hydrogel for painting directly on the surface of MI heart in SD rats. Reprinted with permission from Ref. [64]. Copyright 2018, Wiley.

A) Schematic illustration of BP NSs incorporated hydrogels for upregulated bone formation, (a1) illustrative preparation of double network (DN) hydrogels with different strength, (a2) bioactive nanoengineered (NE) hydrogels composition of black BP NSs and CaP matrix formation in DN hydrogels for bone regenerations. Reprinted with permission from Ref. [36]. Copyright 2019, Wiley. B) Scheme for preparing a conductive and adhesive hydrogel for painting directly on the surface of MI heart in SD rats. Reprinted with permission from Ref. [64]. Copyright 2018, Wiley. Except for polymeric hydrogel patches, other structured polymeric patches have also emerged as a feasible non-invasive matrix for bone and cartilage regeneration. In a recent example of this, PCL/zein/MoS2 (PZM) composite nanofibrous scaffolds were developed through embedding 2D MoS2 nanosheets into polycaprolactone (PCL)/zein (PZ) composite polymeric network based on an electrospinning method [38]. This scaffolds possessed superior biocompatibility, excellent cell attachment, proliferation and differentiation behavior, proving their potential to apply in bone tissue engineering. It has been reported that cartilage regeneration scarcely exhibited innate self-healing ability, which is still currently a great challenge in clinic. Stem cell-derived exosomes (SC-Exos) has emerged as an emerging extracellular nanovesicle for cartilage regeneration to replace stem cell-based treatment. Beyond that, polypyrrole nanoparticles (Ppy-NPs) were applied to incorporate into PCL polymeric matrix for building nanofibrous scaffolds via a low-cost facile strategy [124]. Such PCL/PPy conductive scaffolds could improve the behavior of biocompatibility, bioactivity, and osteogenic differentiation through stimulating by electric, indicating the potential for bone tissue engineering application. Besides, in a more effective paradigm, a series of mechanically activated microcapsules (MAMCs) were designed as a stimuli-triggered delivery system for tissue engineering application [174]. Specially, such mechanical regulation of microcapsules was designed to be as a technique for eliciting tissue repair and regeneration. Thus, inspired by self-healing polymer systems, microcapsules intercalated in a polymer matrix could be disrupted to release the loaded drug upon physical damage. More important, the feasibility of encapsulating transforming growth factor-β3 (TGF-β3) within biocompatible and biodegradable MAMCs was realized for promoting tissue formation through microenvironment modulated mechano-activation. Such design demonstrated a novel strategy for regenerating injured musculoskeletal tissues in mechanical loading environment.

Cardiac constructs and repairs

Myocardial infarction (MI) is well-known one of the most common causes of disability and death in the world. To days, with the development of nanotechnology in medicine, many different sorts of strategies has widely explored for the treatment of MI, such as cardiac patches and injectable biomaterials. The therapeutic efficacy of most approaches is limited by a single method. To improve the efficacy of MI treatment, synergistic therapy strategy was increasingly designed in the recent years. For example, an injectable hydrogel and conductive hydrogel patch was proposed as a combined therapy method for co-administration into the infarcted myocardium [97]. In this system, such conductive patch composed of Fe3+-induced ionic coordination between dopamine-functionalized polypyrrole (DA-PPy) and dopamine-gelatin (GelDA) conjugates was painted on the heart surface, and subsequently cleavable hydrogel in situ formed based on a Schiff base reaction between hydrazided hyaluronic acid (HHA) and oxidized sodium hyaluronic acid (HA-CHO) was intramyocardially injected. Such combined protocol induced a great enhancement of the cardiac function through histological, echocardiographical, and angiogenic outcomes in comparison with a single-mode system. A similar exemplary study in this regard was designed by Liu and his colleagues. A biocompatible paintable conductive hydrogel was designed as cardiac patches for the treatment of MI through Fe3+-triggered simultaneous in situ polymerization of Ppy and dopamine (Fig. 6B) [64]. The Ppy as a unique crosslinker was chemically linked to hyperbranch polymer chains to stabilize the network and endow the gels formed with conductivity. Such resultant conductive and adhesive hydrogel had the capability of conveniently painting as a patch and rapidly bonding onto the beating heart surface owing to dopamine-Fe3+ coordination with no adverse liquid leakage. Such functional patch with similar conductivity to normal myocardium showed the strong bonding to heart for around one month, thus efficiently and increasing the conduction of electrophysiological signals. Besides this, revascularization of MI and the reconstruction of cardiac function exhibited the remarkable improvement. All in all, the translatable suture-free cardiac patch designed in this work has the potential for clinical challenges in cardiac tissue engineering. As is previous demonstrated, it is most important for biomimetic scaffolds for engineered cardiac constructs to improve function of the cardiomyocytes (CMs), such as conductivity, mechanics, and submicrometer structure of the matrix. Thus, lately, carbon nanotubes (CNTs) were chosen to combine with hydrogel for improving cardiac construct. In a simple paradigm, type I collagen hydrogels was integrated with CNTs to form hybrid hydrogel matrix with potentially improved hydrogel strength and conductivity [175]. In comparison with those within pure collagen hydrogels, the result of cardiomyocytes (CMs) treated by the CNT-collagen hybrid hydrogels revealed the enhancement of cardiac cell functions, indicating the great potential of such hybrid hydrogel as biomimetic scaffold for engineered cardiac construct. In another similar example, Khademhossein et al. integrated CNTs with photo-cross-linkable gelatin methacrylate (GelMA) hydrogels to form functional cardiac patches with superior mechanical integrity and enhanced electrophysiological functions through seeding neonatal rat cardiomyocytes [48]. Compared with pristine GelMA hydrogels, CNT-GelMA treated myocardial tissues not only have 85% lower excitation thresholds, but also showed 3 times higher spontaneous synchronous beating rates. The incorporation of CNT within a porous gelatin framework caused the electrically conductive and nanofibrous networks, resulting in optimized cardiac cell adhesion, organization, and cell-cell coupling. The formation of 3D biohybrid actuators released from patches exhibited the controllable linear cyclic contraction/extension, pumping, and swimming actuations. CNT-GelMA cultured cardiac tissues circumvented damage from a cytotoxic compound and a model cardiac inhibitor. Consequently, combination of CNTs into gelatin is promising for neuron and other muscle cells to design multifunctional cardiac constructs with optimized electroactivity, organization, and mechanical integrity. It is well-known that the deprivation of oxygen could cause ischemic heart disease, further inducing the progressive loss and apoptosis of cardiac cells. Thus, oxygen is prerequisite for tissue function and cell survival. Taking advantages of MI, as-generated ischemia leads to tissue necrosis and cell death. Many approaches to regenerate myocardial tissue could intensify the hypoxic stress accompanying with the increased metabolic burden. Therefore, implanted cardiac tissues generally produced hypoxia-induced cell death. Currently, oxygen-self-supplying hydrogels was designed through loading calcium peroxide (CPO) into gelatin methacryloyl (GelMA) [47]. Under hypoxic conditions (1% O2), such hydrogels was observed to gradually release amount of oxygen in 5 days, which is enough to alleviate the metabolic stress from cardiac cells. Particularly, incorporation of CPO in GelMA hydrogels greatly improved cell viability, which is due to that oxygen generation from CPO could reduce cell apoptosis that limited by hypoxia-induced necrosis. Good result was obtained when used such hydrogel to cardiac cells under ischemic conditions. In consequence, this CPO-GelMA can provide an alternative way to improve the regeneration or treatment of infarcted myocardial tissue.

Dermatological disease therapy

With the development of nanomedicine, dermatological disease has attracted tremendous attention owing to their advantages of high prevalence and visible symptoms [176,177]. Currently, flexible polymeric patch has also been extensively applied for diverse skin diseases treatment including actinic keratosis, scars, and acne, etc. [178] For instance, Lotti et al. utilized polymeric MN patches to effectively suppress atrophic acne scar without any severe complication and post-inflammatory hyperpigmentation through enhancing skin roughness and pigmentation spots in patients. Xu's group fabricated a self-administered and drug-free MN patch for effectively inhibiting the abnormal scars post-injury [179]. Currently, by integrating nanomaterials, the polymeric patches could effectively enhance the therapy efficacy of dermatological disease. Retinoids are known to reduce signs of skin aging and improve smooth atrophic acne scars. Frequently, Retinoids were typically applied for improving several skin conditions. As a natural precursor of retinoic acid, retinal could exert the biological activities of retinoids and is beneficial for the treatment of photoaging [180] and acne scarring. Like Patzelt's report, proretinal nanoparticles (PRN) were combined to efficiently deliver retinal for realizing direct dermis targeting [181]. When applied MNs patches, PRN could be loaded and accumulated in the microchannels of skin, as well as recovered retinal concentration in the dermis was obviously higher in comparison with conventional retinal and PRN solution. Hypertrophic scar (HS) is acknowledged to be an abnormal tissue condition caused by burns, injuries, and surgical wounds, which was embodied by a raised, inflamed, and red surface. Usually, HS could produce pruritus, pain, and skin tightening, accompanying by a series of psychological, physical, and cosmetic problems. As one of the most common therapeutics of HS, polymeric patches based drug delivery could enable self-administration, painlessness, good bioavailability, and the fast onset of action. As an attractive paradigm, dissolving MNs were fabricated by hyaluronic acid (HA) to load bleomycin for improved efficient suppression of hypertrophic scars [182]. Such system possessed some superior features of the rapid dissolution of MN to release bleomycin in short time, the recovery of MN treated skin to its sufficient mechanical strength, original status to pierce porcine skin ex vivo, and the protection of stability and activity of bleomycin from HA matrix, leading to its promising feasibility for treating HS. Through in vitro experiment, this method could efficiently prevent the proliferation of human hypertrophic scar fibroblasts (hHSFs) and the secretion of transforming growth factor-b (TGF-b1), showing the potential of this stratagem for HS therapy in an efficient, convenient, and minimally invasive manner. In another similar example, hydroxypropyl-β-cyclodextrin (HP-β-CD) and sodium hyaluronic acid (HA) were applied to build a dissolving MN with improved loading triamcinolone acetonide (TA) for treating HS [183]. Specially, through delivering TA to HS site by MN, mRNA expressions of Collagen I and transforming growth factor-β1 (TGF-β1) were down-regulated to normal, indicating the potential of such system as a convenient and low-pain therapeutic strategy for treating HS. Alternatively, except for drug, some nucleic acids like small interfering RNA (siRNA) also could be loaded and delivered by MNs into skin tissue. Due to some challenges during the delivered siRNAs process including the enzymatic degradation, the difficulty to enter target cells, and the easy leakage from the endosome-lysosome degradation, Xu's group used dissolvable HA as the polymeric matrix and mesoporous silica-coated upconversion nanoparticles (UCNPs@mSiO2) as the siRNA depot to design a nanoparticle-embedding MN system [184]. Under the help of upconversion luminescence imaging or optical coherence tomography (OCT) imaging of UCNPs, the process of MN skin penetration and NP diffusion could be tracked and clearly observed. Through protecting and loading molecular beacons (MBs) and siRNA of SiO2, the targeting transforming growth factor-beta type I receptor (TGF-βRI) could be decreased, implying the potential of this system for abnormal scar treatment. Acne vulgaris is one of the most common chronic inflammatory skin disorders. It is associated with a colonization of bacterium propionibacterium acnes (P. acnes), whose rapid growth could cause metabolic byproducts, cellular damage and bacterial debris to exacerbate the inflammation reaction, thus leading to the psychological and physiological impact to the patients. Despite the strategy using antibiotic cream was developed for acne treatment, low delivery efficiency of drug to bacterium pilosebaceous infected lesions caused poor therapy efficiency. Lately, Gu et al. explored a ROS-responsive MN patch for efficiently treating acne vulgaris through improving the interaction of antibiotics with bacterial (Fig. 7A) [185]. Concretely, during preparing MNs patch process, a methacrylated hyaluronic acid (m-HA)/diatomaceous earth (DE) was integrated as the supporting substrate for promoted healing, and drug-loaded ROS-responsive poly(vinyl alcohol) (RR-PVA) was utilized as the matrix to catch clindamycin (CDM) to form RR-PVA/CDM gel for P. acnes elimination. Under the trigger of ROS (high concentration of H2O2), RR-PVA gel was quickly degraded to release CDM within the P. acnes-infected lesions in controlled and sustained drug release manner after penetrating through epidermis, leading to the effective inhibition of bacteria proliferation with reduced the side effects. Due to the high physical adsorption capability of HA and DE, this patch enabled to accelerate healing of skin through absorbing pus and dead cell debris. Additionally, in vivo experiment realized such bioresponsive patch had the ability to efficiently decrease the skin swelling and ablate bacterial, indicating its promising to treat various other skin diseases.
Fig. 7

A) Illustrative fabrication and mechanism of a ROS-responsive microneedle patch for acne vulgaris treatment. Reprinted with permission from Ref. [185]. Copyright 2018, Wiley. B) Schematic of a detachable microneedle patch for hair loss therapy, (b1) illustrative depiction of Keratin that used to form the polymeric matrix of MNs, (b2) schematics of keratin hydrogel-based MNs encapsulated with MSC-derived exosomes and UK5099-loaded PLGA NPs, (b3) illustrative process of MNs applying to the skin for sustained release of therapeutics, (b4) schematic description of transdermal delivery of HFSC for accelerating a new hair cycle transition and hair regrowth. Reprinted with permission from Ref. [77]. Copyright 2019, American Chemical Society. C) Schematic illustration of transcutaneous MN patch loaded with NPs comprised of Rosi, GOx, CAT and pH-sensitive acetal-modified dextran for the brown remodeling of the white fat. Reprinted with permission from Ref. [186]. Copyright 2017, American Chemical Society.

A) Illustrative fabrication and mechanism of a ROS-responsive microneedle patch for acne vulgaris treatment. Reprinted with permission from Ref. [185]. Copyright 2018, Wiley. B) Schematic of a detachable microneedle patch for hair loss therapy, (b1) illustrative depiction of Keratin that used to form the polymeric matrix of MNs, (b2) schematics of keratin hydrogel-based MNs encapsulated with MSC-derived exosomes and UK5099-loaded PLGA NPs, (b3) illustrative process of MNs applying to the skin for sustained release of therapeutics, (b4) schematic description of transdermal delivery of HFSC for accelerating a new hair cycle transition and hair regrowth. Reprinted with permission from Ref. [77]. Copyright 2019, American Chemical Society. C) Schematic illustration of transcutaneous MN patch loaded with NPs comprised of Rosi, GOx, CAT and pH-sensitive acetal-modified dextran for the brown remodeling of the white fat. Reprinted with permission from Ref. [186]. Copyright 2017, American Chemical Society.

Hair loss therapy

Hair loss is known as a common disorder in humans from diseases, aging, and medications. On account of the social and psychological impacts, increasing population suffered from hair loss. Currently, hair follicle transplantation was main strategy for clinical treatment of hair loss, for example, valproic acid (VPA), a food and Drug Administration (FDA)-approved anticonvulsant drug, was encapsulated into dissolving MN patch to effectively stimulate hair follicle (HF) regrowth by up-regulating Wnt/b-catenin for hair loss therapy [187]. However, this application was limited because of donors' shortage as well as costly and invasive surgery. Additionally, it is promising for hair loss therapy to promote hair follicle regrowth through activating hair follicle stem cells (HFSCs), while some challenges still existed. To enhance the delivery efficiency of hair loss drugs, enable the easy administration and extend the retention of exosomes for hair regrowth, Gu's group fabricated a detachable MN patch based drug delivery system for sustained delivery of HFSC activators to heal hair loss (Fig. 7B) [77]. Herein, such MN patch based system included three parts: hair-derived keratin based hydrogel covered by an HA-based patch, mesenchymal stem cell (MSC)-derived exosomes and UK5099 as the HF stem cells (HFSC) activator loaded into PLGA NPs. Upon administration in hair loss C57BL/6J mouse models, this MN patch based drug delivery system exhibited the improved hair regrowth and pigmentation within 6 days with enhanced curative effect even at a reduced dosage. In short, this polymeric patch had the great potential for hair loss therapy in comparison with subcutaneously injecting exosomes and administrating UK5099.

Obesity therapy

Obesity is one of the most serious public health issues, which could induce various serious associated disorders, including cancer, cardiovascular diseases, and type-2 diabetes. Currently, all sorts of therapy approaches towards obesity, such as diet, pharmacological therapy, physical exercise, and surgeries were limited by undesired side effects or low effectiveness. Currently, the most common approach to treat obesity is oral medications, which could be capable to inhibit fat absorption and suppress appetite through acting on the gastrointestinal tract and central nervous system. However, such traditional strategy could possibly lead to high side effects and poor effectiveness. Thus, to improve the therapeutics efficiency of obesity with reduced side effects, nanomaterials encapsulating anti-obesity drugs integrated with polymeric patches have been widely developed for obesity therapy. As an exemplary work, a NPs integrated MN patch was fabricated to locally brown the white adipose tissue (WAT) for obesity therapy, as depicted in Fig. 7C [186]. In such system, NPs were formed through encapsulating GOx, CAT, rosiglitazone (Rosi) as an agonist of peroxisome proliferator-activated receptor gamma (PPARγ) and pH-sensitive acetal-modified dextran under alginate coating. Subsequently, NPs were further integrated with MN patches consisted of HA matrix for the brown remodeling of the white fat. In brief, with the help of the physiological glucose concentration, GOx could produce gluconic acid to decrease the local pH and CAT consumed H2O2 from the GOx-medicated enzymatic reaction, leading to degrade NPs to release Rosi for WAT browning. In vivo experiments in a diet-induced obesity mouse model demonstrated to increase the energy expenditure and fatty acid oxidation, effectively control body weight through reducing treated fat pad size, showing polymeric patches were promising for clinical treatment of obesity. Besides for this, stimuli-hydrogels are also recently explored for highly effectively treating obesity combined with nanomaterials. Recently, Chen's group incorporated copper sulfide nanodots (CuS-ND) into injectable thermo-responsive hydrogel to induce the ameliorating remodeling based on directly acting on the root of evil according to transdermal mild photothermal therapy [188]. Simultaneously, mirabegron was further co-delivered with such hydrogels, inducing a strong therapeutic synergy. Therefore, this synergistic therapy system realized both high effectiveness and low side effect by virtue of targeted and localized application. In particular, in vivo CuS-ND embedded hydrogel treated high-fat-diet fed mice was found to show the reduced serum levels of triglyceride/insulin/cholestero/glucose, decreased masses and improved insulin sensitivity, proving the high insights to explore effective approaches to inhibit obesity and the associated metabolic disorders.

Immune disease therapy

An autoimmune disease is the result of the immune system accidently attacking your body instead of protecting it. It's still unclear why the immune system does this. With the development of socioeconomics, a rising number of immune diseases including rheumatoid arthritis, hashimoto's autoimmune thyroiditis, graves' disease, celiac disease, rheumatic fever, vitiligo, etc. came out to bring a threat to human health. Up to now, various strategies have been studied for improving antigen immunogenicity. Particularly, a plenty of nanomaterials was introduced to load antigen [189], vaccines [190] and DNA [67,191,192], and then inserted in polymeric patches for vaccination. Giving an example, Duong et al. fabricated a nanopolyplex using cationic amphiphilic conjugates with ovalbumin-expressing plasmid OVA (pOVA) and immunostimulant-polyinosinic:polycytidylic acid (poly(I:C)) to mix with bioresorbable polypeptide matrix to form dissolving MN cocktails [193]. Compared with MN-free nanopolyplex and traditional vaccination, such MN cocktails induced a stronger antigen-specific antibody response and increased the antibody recall memory after challenge. Various DNA vaccines that were loaded into nanomaterials and intradermally delivered by polymeric patches have also been investigated. polylactic-co-glycolic acid-poly-l-lysine/poly-γ-glutamic acid (PLGA-PLL/γPGA) nanoparticles were applied to load a DNA vaccine and integrate with MN patch for Ebola vaccination [67]. In such system, MN patch made vaccine administration minimize trained personnel, while nanoparticles kept vaccine stability even no refrigeration. This study showed a potential strategy for Ebola vaccination for some developing countries where Ebola is most prevalent. In another example, Liao and coworkers designed DNA polyplex vaccine and combined it with MN patches to cause the high immunogenicity via intradermal vaccination and the enhanced vaccine stability during storage outside the cold chain [191]. This system induced stronger immune response, and provided superior vaccine stability at high temperature, indicating its significance to public health and effective vaccination in developing countries. Similarly, DNA was condensed to form cationic nanoparticles by a peptide RALA, which was further integrated with MN patches to build a ‘smart system’ platform for DNA vaccination against cervical cancer [192]. Presently, COVID-19, as a new immune disease, has been prevalent in the world and produced tremendous influence on human life. Although different vaccines toward COVID-19 are always in studying, more approaches were urgent to be developed for effective vaccination. For example, a fingertip-sized patch of needles was being studied to deliver a recombinant protein as the antigen into the skin. Within this context, the nanomaterials integrated polymeric patches showed the probability to be applied in this vaccine against COVID-19.

Conclusion and perspectives

In conclusion, polymeric patches with special flexibility, especially MNs and hydrogel, have attracted great research interests as an attractive therapeutic system against non-cancerous disease with inherent minimal invasive and relatively safe features because of good biocompatibility, superior biodegradation, and high loading capability. Except this, flexible polymeric matrixes embodied more advantages just like the optimized patient compliance, controllable drug release, and improved loading efficiency and permeability of drug, facilitating their extensive application in biomedicine. Though integrating the nanomaterials and flexible polymeric patches, these flexible polymeric systems against non-cancer treatment were rendered to endow with these synergistic merits of lowered systemic side effects and enhanced therapeutic efficacy. Therefore, we herein systematically summarized that various nanomaterials incorporated polymeric patches were explored as a safe and effective therapeutic vehicle for treating non-cancerous diseases, such as diabetes therapy, wound healing, dermatological disease therapy, bone regeneration, cardiac repair, hair repair and obesity therapy. However, in spite of the latest exciting outcomes from nanomaterial integrated polymeric patches for non-cancerous diseases therapy, several challenges and limitation still remained that need to be developed before further clinical translations: (I) the insertion of nanomaterials renders the impact on the mechanical strength of polymeric matrixes; (II) the reliable and principled strategy is limited to accurately reduce the bioavailability of this polymeric system, thus lowering the future clinical translation; (III) the incorporated nanomaterials facilitates the complexity of polymeric patches synthesis; (IV) the characterized methods regarding biosafety of nanomaterials and polymeric matrixes should be performed; (V) most incorporated nanomaterials still exist the long-term biodegradability and clearance of from the body. To raise the solution to these issues, novel nanomaterials incorporated polymer patches with improved chemical, physical and optoelectronic performances regarding therapy as well as superior biocompatibility should be fabricated to meet the specific demands of therapeutics against non-cancerous deceases. Therein, some polymeric matrixes with excellent biodegradability or dissolvability, high biocompatibility, and high drug-loading capability should be designed and developed into flexible patches to encapsulate or modify nanomaterials with amplified therapy efficiency. Additionally, some tailored nanomaterials with special features including ultrasonic, magnetothermal, photoacoustic, chemodynamic, photothermal, and photodynamic effect should be widely explored to realize multi-modal therapeutics against non-cancerous diseases. Anything but this, to retain the inherent properties of the inserted nanomaterials and prevent the interplay between nanomaterials and polymeric matrixes, appropriate nanomaterials as active therapeutic components and soft matrix materials as polymeric templates should be designed to be tailored and coordinated. Particularly, to facilitate the development of treating human diseases like cancer, diabetes, abnormal scars and obesity, an increasing exploration should be given on microscale synthesis of nanomaterials integrated polymeric patch in association with delivery systems. Last but not least, it should pay more attention for the biosafety and bioavailability of both polymeric matrixes and nanomaterials to reduce systemic toxicity. In a word, despite the nanomaterials combined polymeric patch systems have proven to be promising for understanding fundamental therapeutics with enhanced curative treatment, next generation's polymeric patches incorporated by a diversity of novel nanomaterials with multi-functionality are till necessary to explore more application in biomedicine. Furthermore, further clinical translation of nanomaterials based polymeric patches with minimal invasion and cost-effect would be urgently explored for bringing more convenience to patient's life.

CRediT authorship contribution statement

Houjuan Zhu: Writing – original draft, preparation. Justin Mah Jian Qiang: Writing – original draft, co-writing the original draft. Chen Gang Wang: Writing – original draft, co-writing the original draft. Chui Yu Chan: Writing – original draft, co-writing the original draft. Qiang Zhu: Writing – original draft, co-writing the original draft. Enyi Ye: Writing – review & editing, Writing – review & editing. Zibiao Li: Writing – review & editing, Writing – review & editing. Xian Jun Loh: Conceptualization, Writing – review & editing.

Declaration of competing interest

The authors declare no conflict of interest, financial or otherwise.
  156 in total

1.  Diselenide-Bridged Carbon-Dot-Mediated Self-Healing, Conductive, and Adhesive Wireless Hydrogel Sensors for Label-Free Breast Cancer Detection.

Authors:  Hyun Jeong Won; Benny Ryplida; Seul Gi Kim; Gibaek Lee; Ji Hyun Ryu; Sung Young Park
Journal:  ACS Nano       Date:  2020-06-12       Impact factor: 15.881

2.  In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment.

Authors:  Qian Chen; Chao Wang; Xudong Zhang; Guojun Chen; Quanyin Hu; Hongjun Li; Jinqiang Wang; Di Wen; Yuqi Zhang; Yifei Lu; Guang Yang; Chen Jiang; Jun Wang; Gianpietro Dotti; Zhen Gu
Journal:  Nat Nanotechnol       Date:  2018-12-10       Impact factor: 39.213

3.  Fabrication of coated polymer microneedles for transdermal drug delivery.

Authors:  Yang Chen; Bo Zhi Chen; Qi Lei Wang; Xuan Jin; Xin Dong Guo
Journal:  J Control Release       Date:  2017-03-24       Impact factor: 9.776

4.  Intradermal vaccination with hollow microneedles: A comparative study of various protein antigen and adjuvant encapsulated nanoparticles.

Authors:  Guangsheng Du; Rania M Hathout; Maha Nasr; M Reza Nejadnik; Jing Tu; Roman I Koning; Abraham J Koster; Bram Slütter; Alexander Kros; Wim Jiskoot; Joke A Bouwstra; Juha Mönkäre
Journal:  J Control Release       Date:  2017-09-21       Impact factor: 9.776

5.  DNA Microcapsule for Photo-Triggered Drug Release Systems.

Authors:  Yukiko Kamiya; Yoshinobu Yamada; Takahiro Muro; Kazunori Matsuura; Hiroyuki Asanuma
Journal:  ChemMedChem       Date:  2017-10-18       Impact factor: 3.466

Review 6.  The infected wound and its management.

Authors:  J M Bumpous; J T Johnson
Journal:  Otolaryngol Clin North Am       Date:  1995-10       Impact factor: 3.346

Review 7.  Type 2 diabetes: principles of pathogenesis and therapy.

Authors:  Michael Stumvoll; Barry J Goldstein; Timon W van Haeften
Journal:  Lancet       Date:  2005 Apr 9-15       Impact factor: 79.321

Review 8.  Near-infrared light-mediated nanoplatforms for cancer thermo-chemotherapy and optical imaging.

Authors:  Zhenjiang Zhang; Jing Wang; Chunying Chen
Journal:  Adv Mater       Date:  2013-06-06       Impact factor: 30.849

9.  Injectable and responsively degradable hydrogel for personalized photothermal therapy.

Authors:  Changping Wang; Xinyu Wang; Kunyu Dong; Jian Luo; Qiang Zhang; Yiyun Cheng
Journal:  Biomaterials       Date:  2016-07-12       Impact factor: 12.479

10.  Local triple-combination therapy results in tumour regression and prevents recurrence in a colon cancer model.

Authors:  João Conde; Nuria Oliva; Yi Zhang; Natalie Artzi
Journal:  Nat Mater       Date:  2016-07-25       Impact factor: 43.841

View more
  1 in total

Review 1.  Therapeutic application of hydrogels for bone-related diseases.

Authors:  Xiyu Liu; Shuoshuo Sun; Nan Wang; Ran Kang; Lin Xie; Xin Liu
Journal:  Front Bioeng Biotechnol       Date:  2022-09-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.